Haleon HLN
NYSE HLN
$9.86 -0.01 (-0.05%)
As of: Aug 20, 2026 · 3:17 PM EDT

Haleon (HLN) Capital Expenditures Growth (3y) (2025)

Haleon (HLN) Capital Expenditures Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Haleon 43.87 Bn 42.91 Bn - -
2 Teva Pharmaceutical Industries 43.21 Bn 39.55 Bn 2.15 Bn -4.39%
3 Zoetis 31.48 Bn 29.80 Bn 1.05 Bn -11.01%
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn -0.22%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 34.19%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -8.00%
7 Neurocrine Biosciences 15.49 Bn 15.10 Bn 935.80 Mn 4.68%
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn -7.72%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -5.67%

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.03%